BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12102662)

  • 1. Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.
    Heinzerling L; Dummer R; Pavlovic J; Schultz J; Burg G; Moelling K
    Exp Dermatol; 2002 Jun; 11(3):232-40. PubMed ID: 12102662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
    Lucas ML; Heller R
    DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1 beta. II. Mechanism of inhibition: the role of polymorphonuclear leukocytes.
    Neville ME; Pezzella KM; Schmidt K; Galbraith W; Ackerman N
    Cytokine; 1990 Nov; 2(6):456-63. PubMed ID: 1966551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
    Lucas ML; Heller L; Coppola D; Heller R
    Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA.
    Schultz J; Heinzerling L; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 Dec; 7(12):1557-65. PubMed ID: 11228534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
    Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18.
    Nagai H; Hara I; Horikawa T; Fujii M; Kurimoto M; Kamidono S; Ichihashi M
    Cancer Invest; 2000; 18(3):206-13. PubMed ID: 10754989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.
    Keyser J; Schultz J; Ladell K; Elzaouk L; Heinzerling L; Pavlovic J; Moelling K
    Exp Dermatol; 2004 Jun; 13(6):380-90. PubMed ID: 15186325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of plasmid DNAs encoding murine fetal liver kinase 1 extracellular domain, murine interleukin-12, and murine interferon-gamma inducible protein-10 leads to tumor regression and survival in melanoma-bearing mice.
    Ladell K; Heinrich J; Schweneker M; Moelling K
    J Mol Med (Berl); 2003 Apr; 81(4):271-8. PubMed ID: 12684754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
    Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
    Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation.
    Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
    J Invest Dermatol; 2002 Sep; 119(3):541-8. PubMed ID: 12230493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.
    Ugen KE; Kutzler MA; Marrero B; Westover J; Coppola D; Weiner DB; Heller R
    Cancer Gene Ther; 2006 Oct; 13(10):969-74. PubMed ID: 16763607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
    Wang G; Tschoi M; Spolski R; Lou Y; Ozaki K; Feng C; Kim G; Leonard WJ; Hwu P
    Cancer Res; 2003 Dec; 63(24):9016-22. PubMed ID: 14695220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect of cationic liposome-mediated interleukin-12 gene delivery on murine melanoma in vivo].
    Chen W; Shao CS; Shen JG; Pan Y; Zheng S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 34(1):73-6. PubMed ID: 15693129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effects of pNEgr-mIL-12 recombinant plasmid induced by X-irradiation and its mechanisms.
    Yang Y; Liu SZ; Fu SB
    Biomed Environ Sci; 2004 Jun; 17(2):135-43. PubMed ID: 15386939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.
    Triozzi PL; Strong TV; Bucy RP; Allen KO; Carlisle RR; Moore SE; Lobuglio AF; Conry RM
    Hum Gene Ther; 2005 Jan; 16(1):91-100. PubMed ID: 15703492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
    Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
    Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.